Short-duration migraine without aura in children: a retrospective cohort study of attack duration and prognosis

Jiajun Ma1, Zhiwei Yu1, Xin Li1

  • 1Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Chongqing, China.

Frontiers in Neurology
|March 26, 2026
PubMed
Abstract

Insights

Pediatric migraine without aura (MwoA) attacks shorter than 2 hours show similar outcomes to longer attacks. These findings suggest a flexible approach to diagnosing childhood MwoA based on clinical presentation.

Area of Science:

  • Pediatric Neurology
  • Headache Medicine

Background:

  • Migraine without aura (MwoA) is a common pediatric headache disorder.
  • Current diagnostic criteria (ICHD-3) for pediatric MwoA require attack duration of ≥2 hours, a threshold debated for children.
  • Shorter attack durations may be appropriate for diagnosing MwoA in pediatric populations.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of pediatric MwoA with shorter attack durations.
  • To compare outcomes between children with short-duration MwoA (SdMwoA, <2 hours) and those meeting the standard MwoA criteria (≥2 hours).
  • To evaluate the appropriateness of the ICHD-3 duration criterion in pediatric migraine diagnosis.

Main Methods:

  • Retrospective single-center study of children with primary headaches (2018-2023).
  • Patients categorized into SdMwoA (≥1 min to <2 hours) and MwoA (≥2 hours) groups.
  • Demographic and headache data collected; outcomes assessed at 6, 12 months, and last follow-up via clinic visits or phone interviews.
  • Multivariable logistic regression used to identify factors associated with headache outcomes.

Main Results:

  • 192 children included (97 SdMwoA, 95 MwoA); follow-up data available for 69%.
  • MwoA group had longer headache history and prior preventive treatment compared to SdMwoA group.
  • Headache remission or improvement observed in 85.1% of SdMwoA and 81.8% of MwoA patients at last follow-up (p=0.613).
  • Attack duration was not significantly associated with headache outcomes.

Conclusions:

  • Short-duration MwoA and MwoA exhibit comparable short- to mid-term outcomes in children.
  • Findings support a more flexible, child-centered interpretation of the ICHD-3 duration criterion for pediatric migraine.
  • Migraine phenotypes with attacks <2 hours warrant consideration for MwoA diagnosis after excluding other conditions.